Search in:

Artificial Cells, Nanomedicine, and Biotechnology

An International Journal

Volume 47, 2019 - Issue 1

Submit an article Journal homepage

Open access

4,240

Views

CrossRef citations to date

Altmetric

Review

MicroRNA-based potential diagnostic, prognostic and therapeutic applications in triple-negative breast cancer

Qian Tanga Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hunan, ChinaView further author information

Hu Ouyanga Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hunan, ChinaView further author information

Dongxiu Hea Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hunan, China;b Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, Hunan, ChinaCorrespondence[email protected]
View further author information

Cuiyun Yua Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hunan, China;b Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, Hunan, ChinaView further author information

Guotao Tanga Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hunan, China;b Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, Hunan, ChinaView further author information

Pages 2800-2809 | Received 03 Apr 2019, Accepted 24 Jun 2019, Published online: 09 Jul 2019

Cite this article
https://doi.org/10.1080/21691401.2019.1638791
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (29)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (29)

Weiyao Zhong, Yang Zhang, He Zhao, Zihui Liang, Jingwei Shi & Qiang Ma. (2023) High electrochemical active Au-NP/2D zinc-metal organic frameworks heterostructure-based ECL sensor for the miRNA-522 detection in triple negative breast cancer. Talanta 265, pages 124875.
Crossref

Muhammad Tariq, Vinitha Richard & Michael J. Kerin. (2023) MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor Subtype. Biomedicines 11:11, pages 3007.
Crossref

Acharya Balkrishna, Rashmi Mittal & Vedpriya Arya. (2023) Unveiling Role of MicroRNAs in Metastasizing Triple Negative Breast Cancer: From Therapeutics to Delivery. Current Drug Targets 24:6, pages 509-520.
Crossref

Abhishek Kanugo, Rupesh K. Gautam & Mohammad Amjad Kamal. (2022) Recent Advances of Nanotechnology in the Diagnosis and Therapy of Triple- Negative Breast Cancer (TNBC). Current Pharmaceutical Biotechnology 23:13, pages 1581-1595.
Crossref

Peilin Wang, Zihui Liang, Junyi Zhao, Yixin Nie, Shuping Xu & Qiang Ma. (2022) A polarization-resolved ECL strategy based on the surface plasmon coupling effect of orientational Au nanobipyramids patterned structures. Chemical Engineering Journal 448, pages 137630.
Crossref

Kalani M. Wijesinghe, Mazhar A. Kanak, J. Chuck Harrell & Soma Dhakal. (2022) Single-Molecule Sensor for High-Confidence Detection of miRNA. ACS Sensors 7:4, pages 1086-1094.
Crossref

Fu Peng, Li Wang, Liang Xiong, Hailin Tang, Junrong Du & Cheng Peng. (2022) Maackiain Modulates miR-374a/GADD45A Axis to Inhibit Triple-Negative Breast Cancer Initiation and Progression. Frontiers in Pharmacology 13.
Crossref

Zihui Liang, Junyi Zhao, Peilin Wang, Yixin Nie, Shuping Xu & Qiang Ma. (2021) Gold Nanorod Vertical Array-Based Electrochemiluminescence Polarization Assay for Triple-Negative Breast Cancer Detection. Analytical Chemistry 94:2, pages 1221-1229.
Crossref

Qian Tang, Daquan Liu, Hongyuan Chen, Dongxiu He, Wei Pan, Qi Li, Weiquan Xie, Siwei Chen & Cuiyun Yu. (2022) Functionalized PAMAM-Based system for targeted delivery of miR-205 and 5-fluorouracil in breast cancer. Journal of Drug Delivery Science and Technology 67, pages 102959.
Crossref

Yang Liu, Ning Liu, Danfeng Xu, Baohui Wu, Xiaosheng Wu, Xia Sun, Yi Yang & Fengqin Yan. (2021) Hsa‐miR‐599 inhibits breast cancer progression via BRD4/Jagged1/Notch1 axis . Journal of Cellular Physiology 237:1, pages 523-531.
Crossref

Safaa Turkistani, Bruna M. Sugita, Paolo Fadda, Rafael Marchi, Ali Afsari, Tammey Naab, Victor Apprey, Robert L. CopelandJrJr, Michael C. Campbell, Luciane R. Cavalli & Yasmine Kanaan. (2021) A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer. BMC Cancer 21:1.
Crossref

Andrej Rencelj, Nada Gvozdenovic & Maja Cemazar. (2021) MitomiRs: their roles in mitochondria and importance in cancer cell metabolism. Radiology and Oncology 55:4, pages 379-392.
Crossref

Guillermo de Anda-Jáuregui, Jesús Espinal-Enríquez & Enrique Hernández-Lemus. (2021) Highly connected, non-redundant microRNA functional control in breast cancer molecular subtypes. Interface Focus 11:4, pages 20200073.
Crossref

Amal Qattan, Taher Al-Tweigeri, Wafa Alkhayal, Kausar Suleman, Asma Tulbah & Suad Amer. (2021) Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis. Genes 12:4, pages 549.
Crossref

Vasiliki Zolota, Vasiliki Tzelepi, Zoi Piperigkou, Helen Kourea, Efthymia Papakonstantinou, Maria-Ioanna Argentou & Nikos K. Karamanos. (2021) Epigenetic Alterations in Triple-Negative Breast Cancer—The Critical Role of Extracellular Matrix. Cancers 13:4, pages 713.
Crossref

Elif Damla Arisan, Ozge Rencuzogullari, Clara Cieza-Borrella, Francesc Miralles Arenas, Miriam Dwek, Sigrun Lange & Pinar Uysal-Onganer. (2021) MiR-21 Is Required for the Epithelial–Mesenchymal Transition in MDA-MB-231 Breast Cancer Cells. International Journal of Molecular Sciences 22:4, pages 1557.
Crossref

Acharya Balkrishna, Rashmi Mittal & Vedpriya Arya. (2021) Potential Role of miRNA in Metastatic Cascade of Triple-Negative Breast Cancer. Current Cancer Drug Targets 21:2, pages 153-162.
Crossref

Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, Kiavash Hushmandi, Azadeh Hakimi, Amirhossein Zabolian, Salman Daneshi, Saeed Samarghandian, Behzad Baradaran & Masoud Najafi. (2021) MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity. European Journal of Pharmacology 892, pages 173660.
Crossref

Guohui Han, Xiangdong Bai, Hongchuan Jiang & Qiang He. (2021) MicroRNA‑598 inhibits the growth of triple negative breast cancer cells by targeting JAG1. Experimental and Therapeutic Medicine 21:3.
Crossref

Mohammad Hossein Pourhanifeh, Saeed Mehrzadi & Azam Hosseinzadeh. (2021) Melatonin and regulation of miRNAs: novel targeted therapy for cancerous and noncancerous disease. Epigenomics 13:1, pages 65-81.
Crossref

Hussein Sabit, Emre Cevik, Huseyin Tombuloglu, Shaimaa Abdel-Ghany, Guzin Tombuloglu & Manel Esteller. (2021) Triple negative breast cancer in the era of miRNA. Critical Reviews in Oncology/Hematology 157, pages 103196.
Crossref

Mohammad Amir Mishan, Mohammad Amin Khazeei Tabari, Javad Parnian, Jafar Fallahi, Abdolkarim Mahrooz & Abouzar Bagheri. (2020) Functional mechanisms of miR ‐192 family in cancer . Genes, Chromosomes and Cancer 59:12, pages 722-735.
Crossref

Asadoor Amirkhani Namagerdi, Danila d’Angelo, Francesca Ciani, Carmelina Antonella Iannuzzi, Francesco Napolitano, Luigi Avallone, Michelino De Laurentiis & Antonio Giordano. (2020) Triple-Negative Breast Cancer Comparison With Canine Mammary Tumors From Light Microscopy to Molecular Pathology. Frontiers in Oncology 10.
Crossref

Ishita Gupta, Balsam Rizeq, Semir Vranic, Ala-Eddin Al Moustafa & Halema Al Farsi. (2020) Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets. International Journal of Molecular Sciences 21:18, pages 6750.
Crossref

Wanting Zhang, Feixiang Zhou, Danjie Jiang, Yingying Mao & Ding Ye. (2020) Association of the Expression Level of miR-16 with Prognosis of Solid Cancer Patients: A Meta-Analysis and Bioinformatic Analysis. Disease Markers 2020, pages 1-9.
Crossref

Ruixiang Gao, Zhen Wang, Qiang Liu & Chunmei Yang. (2020) MicroRNA-105 plays an independent prognostic role in esophageal cancer and acts as an oncogene. Cancer Biomarkers 27:2, pages 173-180.
Crossref

Lisa Linck-Paulus, Claus Hellerbrand, Anja K. Bosserhoff & Peter Dietrich. (2020) Dissimilar Appearances Are Deceptive–Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma. Cells 9:1, pages 114.
Crossref

Ziyu Ning, Shuang Yu, Yanqiao Zhao, Yang Wang, Qi Fan, Tianming Song & Xiaoyang Yu. (2020) Survival Marker miRNA-Mediated Subpathways of Breast Invasive Carcinoma Derived From Activity Profile. IEEE Access 8, pages 160947-160956.
Crossref

Ruixiang Gao, Zhen Wang, Qiang Liu & Chunmei Yang. (2019) MicroRNA-105 plays an independent prognostic role in esophageal cancer and acts as an oncogene. Cancer Biomarkers, pages 1-8.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

MicroRNA-based potential diagnostic, prognostic and therapeutic applications in triple-negative breast cancer

Articles from other publishers (29)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

MicroRNA-based potential diagnostic, prognostic and therapeutic applications in triple-negative breast cancer

Citations (29)

Articles from other publishers (29)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date